(Q71974151)
Statements
Graft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation are donor-derived (English)
B. J. Boughton
A. W. Simpson
T. A. Phaure
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference